'Ldv sof' presentation slideshows

Ledipasvir-Sofosbuvir ( Harvoni )

Ledipasvir-Sofosbuvir ( Harvoni ). Prepared by: David H. Spach, MD and H. Nina Kim, MD MSc Last Updated: December 15, 2015. Ledipasvir-Sofosbuvir ( Harvoni ). Background and Dosing. Ledipasvir-Sofosbuvir ( Harvoni ).

1.28k views • 127 slides

CCO Official Conference Coverage: Clinical Impact of New Data From AASLD 2015

CCO Official Conference Coverage: Clinical Impact of New Data From AASLD 2015. CCO Official Conference Coverage of the 2015 Annual Meeting of the American Association for the Study of Liver Diseases , November 13-17 , 2015 San Francisco, California. In partnership with.

471 views • 47 slides

What You Need to Know - Medication Access

What You Need to Know - Medication Access. Sarah Spencer, PharmD August 1, 2018. Our passion is personal. Connecting with you and your hepatitis C patients, so they can finally connect to a cure. Walgreens Local Specialty Pharmacy. Closer to you and your patients

174 views • 17 slides

Ledipasvir-Sofosbuvir +/- 3 rd DAA in HCV Genotype 1 SYNERGY

249 views • 12 slides

Ledipasvir-Sofosbuvir for 8 or 12 weeks in HCV GT1 ION-3

236 views • 9 slides

Ledipasvir-Sofosbuvir +/- Ribavirin in HCV Genotype 1 ION-1

92 views • 9 slides

Ledipasvir-Sofosbuvir +/- 3 rd DAA in HCV Genotype 1 NIAID SYNERGY: Genotype 1

219 views • 8 slides

Sofosbuvir-Ledipasvir +/- Ribavirin in GT-1 LONESTAR Trial

72 views • 7 slides

Sofosbuvir + ( Ledipasvir or GS-9669) +/- Ribavirin in GT-1 ELECTRON Trial ( A rms 12-17 & 22)

170 views • 6 slides

Ledipasvir + Sofosbuvir +/- Ribavirin in GT 1-3 ELECTRON 2

356 views • 6 slides

Ledipasvir-Sofosbuvir +/- 3 rd DAA in HCV Genotype 1 NIH SYNERGY

65 views • 6 slides